Financial Information

Shareholder Tools
Search Investor Relations

In June 2013, Mirati Therapeutics, Inc. became the ultimate parent corporation of MethylGene Inc. and subsidiaries by a court and shareholder-approved plan of arrangement.

Here you will find a summary of Mirati Therapeutics Inc.'s latest financial information.

Latest Earnings Release and 10-Q

  Date Filed Format Size
Fourth Quarter Financial Results HTML file N/A
Third Quarter Form 10-Q Nov 12, 2013 HTML file  PDF file   View XBRL 452.5 KB   Add to Briefcase

Latest Annual Report and 10-K

  Date Filed Format Size
2012 Annual Report   PDF 955.2 KB   Add to Briefcase
Form 10-K Mar 17, 2014 HTML file  PDF file   View XBRL 822.2 KB   Add to Briefcase

Latest Proxy Statement

  Date Filed Format Size
Proxy Statement Apr 17, 2014 HTML file  PDF file 626.4 KB   Add to Briefcase
Add to Briefcase = add PDF file to Briefcase
Subscribe to News

Please fill out the form below to be added to Mirati's press release distribution list.

Your Name (required)

Your Company

Your Email (required)